Lars Frison

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Gregory Y.H. Lip, Lars Frison, Jonathan L. Halperin et al. · Journal of the American College of Cardiology · 2010 · 1.1K citations

Medicine, Cardiology, Hematology +16

Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation

Gregory W. Albers, Hans‐Christoph Diener, Lars Frison et al. · JAMA · 2005 · 665 citations

Medicine, Pharmacology, Pharmacotherapy +17

Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design

Lars Frison, Stuart Pocock · Statistics in Medicine · 1992 · 605 citations

Public Health, Biostatistics, Experimental Design +15

Identifying Patients at High Risk for Stroke Despite Anticoagulation

Gregory Y.H. Lip, Lars Frison, Jonathan L. Halperin et al. · Stroke · 2010 · 494 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement

Giancarlo Agnelli, Alexander T. Cohen, Ola E. Dahl et al. · Thrombosis and Haemostasis · 2003 · 252 citations

Medicine, Orthopaedic Surgery, Surgery +17